Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | BCAT1 | P54687 | 7/20 | 0.40 |
| ▸ | BCAT2 | O15382 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HSPB1 | P04792 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CCR6 | P51684 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7027089 | 0.93 | HSPB1 (0.40) | HPGDBCAT1BCAT2LMNAHSPB1 | |
| SCHEMBL7015227 | 0.93 | BCAT1 (0.35) | HPGDBCAT1BCAT2LMNASMN1; SMN2 | |
| SCHEMBL7020145 | 0.89 | BCAT1 (0.37) | HPGDBCAT1BCAT2 | |
| SCHEMBL7026595 | 0.89 | BCAT1 (0.41) | HPGDBCAT1BCAT2SMN1; SMN2HSPB1 | |
| SCHEMBL7019065 | 0.89 | MERTK (0.35) | BCAT1BCAT2LMNAPOLBL3MBTL1 | |
| SCHEMBL7024892 | 0.88 | BCAT1 (0.43) | BCAT1BCAT2ATMGAA | |
| SCHEMBL7015650 | 0.87 | PDE7A (0.41) | BCAT1BCAT2HSPB1MAPTGPR55 | |
| SCHEMBL7015275 | 0.87 | ALDH1A1 (0.42) | BCAT1BCAT2LMNASMN1; SMN2ATM | |
| SCHEMBL7023372 | 0.86 | BCAT1 (0.42) | BCAT1BCAT2 | |
| SCHEMBL7021987 | 0.85 | PDE7A (0.41) | BCAT1BCAT2ATMHSPB1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455469-B1 | SUBSTITUTED ACETANILIDE DERIVATIVE IN COMBINATION WITH OTHER HERBICIDE TO GIVE EFFECTIVE WEED CONTORL | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-09-24 | — | — | US | claimed |
| US-6806367-B2 | CHEMICAL INTERMEDIATES; HERBICIDES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-10-19 | — | — | US | disclosed |
| EP-0973395-B1 | DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISK AMERICAS INC (US) | 2003-12-03 | — | — | EP | disclosed |
| US-20030187264-A1 | Process for producing carbonyl hydrazones | ISHIHARA SANGYO KAISHA, LTD. | 2003-10-02 | — | — | US | disclosed |
| US-20030096990-A1 | Processes for preparing 3-phenyl-2,4(1H, 3H)-pyrimidinediones | ISHIHARA SANGYO KAISHA, LTD. | 2003-05-22 | — | — | US | disclosed |
| US-6479435-B1 | OR DIARYL SULFIDES, 1-(4-CHLORO-2-FLUORO-5-(2-PYRIMIDYLOXY)PHENYL)-4-DIFLUOROMETHY L-3-METHYL-1,4-DIHYDRO-1,2,4-TRIAZOLIN-5-ONE FOR EXAMPLE | ISK AMERICAS INCORPORATED | 2002-11-12 | — | — | US | disclosed |
| US-20020161224-A1 | Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them | PULMAN DAVID A (US) | 2002-10-31 | — | — | US | disclosed |
| US-6455469-B1 | SUBSTITUTED ACETANILIDE DERIVATIVE IN COMBINATION WITH OTHER HERBICIDE TO GIVE EFFECTIVE WEED CONTORL | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020107148-A1 | Herbicidal composition | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-08-08 | — | — | US | disclosed |
| US-6333296-B1 | FOR CONTRILLING WEEDS | ISK AMERICAS INCORPORATED | 2001-12-25 | — | — | US | disclosed |
| US-6303543-B1 | Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2001-10-16 | — | — | US | disclosed |
| EP-0973395-A4 | DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISK AMERICAS INC (US) | 2001-10-04 | — | — | EP | disclosed |
| US-6121201-A | HETEROARYL SUBSTITUTED HALO-PYRAZOLE SUBSTITUTED DIARYL ETHERS OR THIOETHERS | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
| EP-0973395-A1 | DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISK Americas Incorporated (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998041093-A1 | DIARYL ETHERS AND PROCESSES FOR THEIR PREPARATION AND HERBICIDAL AND DESICCANT COMPOSITIONS CONTAINING THEM | ISK AMERICAS INCORPORATED (US) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096990-A1 | Processes for preparing 3-phenyl-2,4(1H, 3H)-pyrimidinediones | HPD, DDT, DPYD | HPGD 377/4885BCAT1 2162/4885BCAT2 2188/4885 |
| US-20020107148-A1 | Herbicidal composition | CPS1, HADHB, DDT | HPGD 889/4885BCAT1 218/4885BCAT2 461/4885 |
| US-20020161224-A1 | Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them | HDHD5, DDT, CBR3 | HPGD 1405/4885BCAT1 1455/4885BCAT2 1131/4885 |
| US-20030187264-A1 | Process for producing carbonyl hydrazones | CBR3, CBR1, RCOR3 | HPGD 2734/4885BCAT1 2027/4885BCAT2 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.